[Evaluation in clinical trials of some drug associations. (L-dopa, neuroleptics and lithium carbonate)].
D001480:Basal Ganglia Diseases / Q000188:drug therapy; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D005116:Extrapyramidal Tracts; D006801:Humans; D008094:Lithium / Q000627:therapeutic use*; D001523:Mental Disorders / Q000188:drug therapy*; D009069:Movement Disorders / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D014149:Tranquilizing Agents; D004295:Dihydroxyphenylalanine; D008094:Lithium
Valutazione sulla sperimentazione clinica di alcune associazioni psicofarmacologiche. (L-dopa-neurolettici-carbonato di litio.